KISQALI

ribociclib · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

87 regulatory and trial events tracked for KISQALI, covering 2016-11-23 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Kisqali (ribociclib succinate) — Novartis Europharm Limited